{
    "code": "52027993",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52027993",
    "time": "2022-12-23 07:15:57",
    "許可證字號": "衛部藥輸字第027993號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "114\/11\/30",
    "發證日期": "109\/11\/30",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA05202799301",
    "中文品名": "立滅伏膜衣錠100毫克",
    "英文品名": "Zimagliv 100 (Imatinib Mesilate Tablets 100mg)",
    "適應症": "治療正值急性轉化期（BLAST CRISIS）、加速期或經ALPHA-干擾素治療無效之慢性期的慢性骨髓性白血病（CML）患者。治療成年人無法手術切除或轉移的惡性胃腸道基質瘤。用於治療初診斷為慢性骨髓性白血病（CML）的病人。●治療初診斷為費城染色體陽性急性淋巴性白血病（Ph+ALL）且併用化療之成年及兒童患者。●做為治療成人復發性或難治性費城染色體陽性急性淋巴性白血病（Ph+ALL）之單一療法。●治療患有與血小板衍生生長因子受體（PDGFR）基因重組相關之骨髓發育不全症候群（MDS）／骨髓增生性疾病（MPD）之成人患者。●治療患有系統性肥大細胞增生症（SM），限具FIP1L1-PDGFR基因變異且不具有c-Kit基因D816V突變之成人患者。●治療嗜伊紅性白血球增加症候群（HES）與／或慢性嗜伊紅性白血病（CEL）且有血小板衍生生長因子受體（PDGFR）基因重組之成人患者。●作為成人KIT（CD 117）陽性胃腸道基質瘤完全切除（complete gross resection）後之術後輔助治療。●治療無法手術切除、復發性或轉移性且有血小板衍生生長因子受體（PDGFR）基因重組之隆突性皮膚纖維肉瘤（DFSP）之成人患者。",
    "劑型": "116膜衣錠",
    "包裝": "2-1000錠PVC\/ACLAR-AL 鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "監視期滿學名藥",
    "監視期限": "",
    "主成分略述": "IMATINIB MESYLATE",
    "限制項目": "02輸　入 24監視期滿學名藥",
    "申請商名稱": "640102B347  毅有生技醫藥股份有限公司",
    "申請商地址": "新北市中和區中山路２段332巷37號13樓",
    "主製造廠": [
        {
            "製造廠名稱": "FIN1097000  ZYDUS LIFESCIENCES LIMITED",
            "製造廠廠址": "PLOT NO. 1-A\/1 &amp; 2, PHARMEZ, (SPECIAL ECONOMIC ZONE), MATODA, SARKHEJ-BAVIA N.H. NO.8A, TAL. SANAND DIST. AHMEDABAD, GUJARAT STATE, INDIA-382 213",
            "製造廠公司地址": "",
            "製造廠國別": "INDIA",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1013000710",
            "成分名稱": "IMATINIB MESYLATE",
            "含量描述": "(eq. to Imatinib.....100mg)",
            "含量": "119.5000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Tablet Photos_Imatinib Tablets 100-110-03-03.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027993&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Zimagliv 100 中文仿單_2020 Dec-110-03-03.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027993&Seq=001&Type=9"
        },
        {
            "title": "ZIMAGLIV TABS 100MG_AF_10'S_Taiwan_2020 Dec_for reg-110-03-03.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027993&Seq=002&Type=8"
        },
        {
            "title": "ZIMAGLIV TABS 100MG_CT_6X10'S_Taiwan_2020 Dec_for reg-110-03-03.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027993&Seq=001&Type=8"
        }
    ]
}